10.1097/HC9.0000000000000266 132 TachmatzidiE
New and Emerging Weight Loss Medications The world of weight loss is changing fast with new medicines coming out
BPC-157 Research Education Hub Structured reference guides for researchers working with BPC-157 peptides in laboratory settings
The first randomized, double-blind, placebo-controlled phase 2 study to evaluate the efficacy and safety of an FcRn inhibitor, rozanolixizumab, in patients with leucine-rich gliomainactivated 1 autoimmune encephalitis
With Epithalon injections 5 times a week the number of tumors was decreased and also prevented the development of metastases
Recalls & Warnings March 04, 2008 Airborne Settles Lawsuit Over False Advertising of its "Miracle Cold Buster" On March 4, 3008, the Center for Science in the Public Interest (CSPI) announced that the makers of Airborne -- a multivitamin and herbal supplement whose labels and ads falsely claimed that the product cures and prevents colds -- will refund money to consumers who bought the product, as part of a
